HEART Score Calculator for Chest Pain Risk Stratification

About

The HEART score (History, ECG, Age, Risk factors, Troponin) was developed by Six et al. and first published in the Netherlands Heart Journal in 2008 as a practical bedside tool for risk stratification of patients presenting with chest pain to the emergency department. The original derivation and validation cohort included 2,448 patients presenting to the emergency department with chest pain, of whom 13.6% experienced a major adverse cardiac event within 30 days. Unlike many other risk scores that were derived from highly selected clinical trial populations, the HEART score was developed in a real-world emergency department setting, enhancing its generalizability to everyday clinical practice. The score assigns 0, 1, or 2 points to each of five components: History (level of suspicion based on presenting symptoms), ECG (normal, non-specific repolarization disturbance, or significant ST-segment deviation), Age (<45, 45-64, ≥65 years), Risk factors (traditional cardiovascular risk factors), and Troponin (normal, 1-3x normal, or ≥3x normal), yielding a total score ranging from 0 to 14. The score has been externally validated in numerous cohorts across Europe, North America, Australia, and Asia, consistently demonstrating excellent discrimination for 30-day MACE with c-statistics ranging from 0.83 to 0.90. Its evidence level is Grade B, supported by multiple prospective validation studies. The HEART score is now recommended by several national and international emergency medicine guidelines for chest pain evaluation and is widely implemented in emergency department triage protocols globally.

Formula

HEART Score = History (0-2) + ECG (0-2) + Age (0-2) + Risk Factors (0-2) + Troponin (0-2)

The HEART score comprises five components, each scored from 0 to 2 based on predefined criteria, yielding a total between 0 and 14. History (H): The clinician judges the level of suspicion based on the patient's presenting symptoms. Slightly suspicious or non-specific symptoms (atypical chest pain) score 0, moderately suspicious (symptoms that could represent ACS) score 1, and highly suspicious (classic anginal symptoms) score 2. ECG (E): A normal ECG scores 0, non-specific repolarization disturbance (minor ST/T-wave changes without diagnostic significance) scores 1, and significant ST-segment depression (≥0.5 mm) scores 2. Age (A): Patients under 45 score 0, those aged 45-64 score 1, and those aged 65 or older score 2. Risk factors (R): No known cardiovascular risk factors score 0, 1-2 risk factors (hypertension, diabetes, hyperlipidemia, smoking, obesity, family history of CAD) score 1, and 3 or more risk factors score 2. Troponin (T): Normal troponin (≤99th percentile of normal population) scores 0, elevation of 1-3 times the upper reference limit scores 1, and elevation ≥3 times the upper reference limit scores 2. The total score stratifies patients into three risk categories: low risk (score 0-3, 30-day MACE rate 0.9-1.7%), moderate risk (score 4-6, MACE rate 11-16%), and high risk (score 7-14, MACE rate 50-65%). The score is designed to be calculated rapidly at the bedside, typically within minutes of completing the history, ECG, and initial troponin assessment.

Score Interpretation

The HEART score has transformed emergency department management of chest pain by enabling evidence-based risk stratification that balances patient safety with resource utilization. It is endorsed by the American College of Emergency Physicians (ACEP) clinical policy for chest pain evaluation and is widely incorporated into institutional protocols. Its primary clinical impact is the identification of low-risk patients (HEART score 0-3), who comprise approximately 30-40% of chest pain presentations and have a <2% rate of 30-day MACE. These patients can be safely considered for early discharge without mandatory stress testing or advanced cardiac imaging, reducing unnecessary admissions, healthcare costs, and emergency department overcrowding. Studies have demonstrated that implementation of HEART score-based protocols reduces hospital admissions by 15-25% without increasing missed MACE rates. For moderate-risk patients (score 4-6), the score justifies admission for observation with serial troponin measurements and further ischemic evaluation such as stress testing or coronary CT angiography. For high-risk patients (score 7-14), the score supports urgent cardiology consultation and consideration of early invasive angiography. The HEART score has also been integrated into accelerated diagnostic protocols (ADPs) such as the HEART Pathway, which combines the score with serial troponin measurements at 0 and 3 hours to further refine risk stratification. Modified versions incorporating high-sensitivity troponin assays have maintained excellent diagnostic performance while enabling even faster rule-out protocols.

Reference Ranges